Welgene Biotech
TPEX:6661
NT$ 18,90
NT$0,00 (0,00%)
18,90 NT$
NT$0,00 (0,00%)
End-of-day quote: 03/23/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

NT$1,43
Earnings Per Share
NT$21,23
Revenue Per Share
41,54%
Gross Margin %
NT$0,44 B
Market Cap
NT$0,14 B
Long-Term Debt
Earnings Per Share
NT$1,43
Revenue Per Share
NT$21,23
Gross Margin %
41,54%
Market Cap
NT$0,44 B
Long-Term Debt
NT$0,14 B

Financials

Year Year 2026 2025 2024 2020
EPS Earnings Per Share NT$1,43 NT$1,43 NT$1,43
Earnings Earnings NT$26,81M NT$33,32M NT$29,60M
RPS Revenue Per Share NT$0,00 NT$21,23 NT$17,09 NT$19,23
Revenue Revenue NT$0,00M NT$398,10M NT$398,10M NT$398,10M
OCF Operating Cash Flow NT$0,00M NT$0,00M NT$0,00M NT$0,00M
FCF Free Cash Flow NT$0,00M NT$0,00M NT$0,00M NT$0,00M
OM Operating Margin 0,00% 0,03% -0,26% 8,85%
GM % Gross Margin % 0,00% 41,54% 42,11% 40,77%
FCFS Free Cash Flow Per Share NT$0,00 NT$-0,31 NT$2,20 NT$1,73
LT Debt Long-Term Debt N/A NT$141,19M NT$95,58M N/A
Sha. Stocks 18,75M 18,75M 23,3M 20,7M
×